Nashville Biosciences Creates The Alliance for Genomic Discovery

Nashville Biosciences (NB), a wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), has announced a partnership with five major pharmaceutical companies to form the Alliance for Genomic Discovery.  BioTN and Life Science Tennessee applaud this momentous transaction and its promise to change the future of medicine and, specifically, Tennessee’s direct involvement in the creation of [...]

2023-07-20T15:07:13-06:00July 19th, 2023|General, News|

Knoxville Named One of the Top Emerging Markets for Life Science Researchers

Knoxville Total 2022 NIH funding: $11M  In Knoxville, Tennessee, the NIH’s 2022 funding primarily went to the University of Tennessee, CBRE reported, and the city touts 1,530 life sciences researchers. Knoxville’s biotech industry is supported by Life Science Tennessee, a nonprofit organization with a member network of over 130 companies, including biotechs, venture capitalist firms, academic institutions [...]

2023-07-26T14:35:04-06:00July 12th, 2023|General, News|

Life Science Policy & Advocacy Update

WATCH: The Policy & Advocacy Update on November 29 featured seasoned EBG policy professionals highlighting recent developments at multiple levels of government policy. Life Science Tennessee members joined us in-person and online as we covered important membership updates as well as our annual board vote.  Featuring: Rep. John Ray Clemmons, Philo Hill, Machelle Shields, and [...]

2022-12-27T11:32:52-06:00November 15th, 2022|General, News|

New Member Spotlight: Helix Biotech, Inc.

Knoxville-based Helix Biotech, Inc. joins Life Science Tennessee's membership. We sat down with Helix's founder, Graham Taylor to learn more about the company:   Tell us about Helix Biotech.  Helix Biotech is a Customer and Quality focused Pharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in Lipid Nanoparticles, Liposomes, and Hybrid Nanoparticles. Helix Biotech performs [...]

2022-11-01T08:55:42-06:00November 1st, 2022|General, News|

Patents2Products Allum, Erika Dillard is Taking Pop Check Technologies to the Next Level 

Being the first person admitted into the Patents2Products program, Dr. Erika Dillard had the vision and drive to create something special with PopCheck Technologies. Since the company's inception in 2019, PopCheck has been on a meteoric rise and has recently been selected to participate in the esteemed MedTech Innovator in Boston this October. The Memphis-based startup that analyzes and predicts the development of venous blood [...]

2022-08-23T11:02:05-06:00August 23rd, 2022|General, News|

New Member Spotlight: Currax Pharmaceuticals

Welcome new Life Science Tennessee member, Currax Pharmaceuticals! We asked George Hampton, President and CEO of Currax, to tell us about his company's mission to expand access to medicine and why Tennessee is poised for more life science industry growth. Tell us about Currax. Currax Pharmaceuticals is a specialty biopharmaceutical company dedicated to expanding access [...]

2021-10-21T09:37:07-06:00October 21st, 2021|News|

New Member Spotlight: Daxor

Welcome new Life Science Tennessee member, Daxor! We asked Michael Feldschuh, CEO and President of Daxor Corporation, to talk about the company's innovative manufacturing and how better information can lead to better healthcare outcomes. Tell us about Daxor. Daxor is an innovative medical diagnostics company focused on blood volume measurement technology.  We manufacture in Tennessee [...]

2021-08-16T07:39:49-06:00August 16th, 2021|News|

Press Statement: May 12 2021

TN General Assembly Funds SBIR/STTR Matching Fund at $7M in Final Budget LST-supported legislation will expand access to medical innovations and grow industry in TN Nashville, Tenn. – Life Science Tennessee (LST), a statewide member organization for life science companies, research institutions and economic development groups, commends the Tennessee General Assembly for supporting numerous bills [...]

2021-05-12T10:33:04-06:00May 12th, 2021|News|
Go to Top